In DURATION-8, 695 patients were randomized to receive exenatide QW plus dapagliflozin (n = 231), exenatide QW (n = 231), or dapagliflozin (n = 233)
The pace at which you lose weight with GLP-1 medications depends on various factors, including your baseline weight, diet, level of physical activity, and overall health
Mechanism Behind GLP-1 RAs Kidney Protection A unique aspect of GLP-1 receptor agonists lies in their ability to reduce oxidative stress, a process that, when unchecked, can accelerate kidney damage in diabetic patients
Campisciano G, Florian F, D'Eustacchio A, et al
To demonstrate the role of GSH in chemotherapy resistance, we analyzed transcriptomic data from chemotherapy patient samples in the GEO database and collected post-chemotherapy samples from patients who underwent neoadjuvant chemotherapy, assessing the expression levels of GSH and GSH synthesis-related antioxidant enzymes
Now the initial response is, well, Medicare prices, that's awful